Understanding the patient perspective of the English community pharmacy medicines use review (MUR)

Research in Social and Administrative Pharmacy

Volumn 9, Issue 6, 2013, Pages 949-957

  Latif, Asam ^a   Boardman, Helen F ^a   Pollock, Kristian ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Community pharmacy; Medicines Use Reviews; Patients; Pharmacists

Indexed keywords

ADULT; AGED; ARTICLE; DRUG USE; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN RELATION; MALE; MEDICINES USE REVIEWS; MIDDLE AGED; PATIENT; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; UNITED KINGDOM; VERY ELDERLY;

COMMUNITY PHARMACY; MEDICINES USE REVIEWS; PATIENTS; PHARMACISTS;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION REVIEW; ENGLAND; FEMALE; HEALTH POLICY; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS;

EID: 84887608054     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.01.005     Document Type: Article

References (50)

1. Ernst F.R., Grizzle A.J. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001, 41:192-199.
2. Horne R., Weinman J., Barber N., et al. Concordance, Adherence and Compliance in Medicine Taking 2005, National Co-ordinating Centre for NHS Service Delivery and Organisation, London.
3. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
4. Trueman P., Taylor D.G., Lowson K., et al. Evaluation of the Scale, Causes and Costs of Waste Medicines 2010, Report of DH funded national project, York Health Economics Consortium and The School of Pharmacy, University of London, York and London.
5. Donovan J.L. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care 1995, 11:443-455.
6. Fallsberg M. Reflections on medicines and medication: a qualitative analysis among people on long-term drug regimens. Linkoping Studies in Education 1991, Linkoping University, Sweden, Dissertations No. 31.
7. Pound P., Britten N., Morgan M., et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005, 61:133-155.
8. Pharmacy in England: Building on Strengths - Delivering the Future 2008, Department of Health, Department of Health, London.
9. Blenkinsopp A., Bond C., Raynor D.K. Medication reviews. Br J Clin Pharmacol 2012, 74:573-580.
10. Edmund J., Calnan M.W. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med 2001, 53:943-955.
11. Domiciliary Medication Management-Home Medicines Review. Helping Your Patients Manage Their Medicines at Home 2001, Commonwealth Department of Health and Aged Care, Commonwealth Department of Health and Aged Care, Canberra, Available at:, Accessed 06.09.12. http://pivotwest.org.au.titan.imagin8.com/icms_docs/12623_What_is_DMMR_.pdf.
12. The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2005, Department of Health, Department of Health, London, Available at:, Accessed 06.09.12. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4107597.pdf.
13. Dolovich L., Gugnon A., McAiney C.A., et al. Initial pharmacist experience with the Ontario-based MedsCheck program. CPJ 2008, 141:339-345.
14. Lee E., Braund R., Tordoff J. Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008. N Z Med J 2009, 122:26-35.
15. Niquille A., Lattmann C., Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract 2010, 8:35-42.
16. Clyne W., Blenkinsopp A., Seal R. A Guide to Medication Review 2008, National Prescribing Centre, Liverpool, Available at:, Accessed 02.01.13. http://www.npc.nhs.uk/review_medicines/intro/resources/agtmr_web1.pdf.
17. Portlock J., Holden M., Patel S. A community pharmacy Medicines Use Review service in Hampshire and the Isle of Wight. Pharm J 2009, 282:109-112.
18. Bagole L.E., Beaumont A., Morgan I. Outcomes of Medicines Use Reviews for people with asthma. Int J Pharm Pract 2007, 15(suppl 2):B66.
19. Wilcock M., Harding G. What do pharmacists think of MURs and do they change prescribed medication?. Pharm J 2008, 281:163-167.
20. Youssef S., Hussain D., Upton D. Do patients perceive any benefit from Medicines Use Reviews offered to them in community pharmacies?. Pharm J 2010, 284:165-166.
21. Blenkinsopp A., Bond C., Celino G., et al. National Evaluation of the New Community Pharmacy Contract 2007, Pharmacy Practice Research Trust, London, Available at:, Accessed 06.09.12. http://www.pprt.org/Documents/ResearchFunding/National_evaluation_of_the_new_community_pharamcy_contract.pdf.
22. Bradley F., Wagner A.C., Elvey R., et al. Determinants of the uptake of Medicines Use Reviews (MURs) by community pharmacies in England: a multi-method study. Health Pol 2008, 88:258-268.
23. Latif A., Pollock K., Boardman H. The contribution of the Medicines Use Review (MUR) consultation to counseling practice in community pharmacies. Patient Educ Couns 2011, 83:336-344.
24. McDonald R., Cheraghi-Sohi S., Sanders C., et al. Professional status in a changing world: the case of Medicines Use Reviews in English community pharmacy. Soc Sci Med 2010, 71:451-458.
25. Urban R., Rivers P., Morgan J. Perceptions of medicine use reviews-the views of community pharmacists within a West Yorkshire Primary Care Trust. Pharm J 2008, 281:303-305.
26. Livingstone C. Onwards and upwards with target MURs. Pharm J 2010, 284:57-60.
27. Charmaz K. Constructing Grounded Theory. A Practical Guide through Qualitative Analysis 2006, Sage, Thousands Oaks.
28. Ziebland S., McPherson A. Making sense of qualitative data analysis: an introduction with illustrations from DIPEx (personal experiences of health and illness). Med Educ 2006, 40:405-414.
29. Silverman D. Interpreting Qualitative Data - Methods for Analysing Talk, Text and Interaction 1993, Sage Publication, Thousand Oaks: CA.
30. Anderson C., Blenkinsopp A., Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002. Health Expect 2004, 7:191-202.
31. Hassell K., Noyce P., Rogers A., et al. Advice provided in British community pharmacies: what people want and what they get. J Health Serv Res Po 1998, 3:219-225.
32. Carter S., Chen T., White L. Home Medicines Reviews: a quantitative study of the views of recipients and eligible non-recipients. Int J Pharm Pract 2012, 20:209-217.
33. Britten N. Medicines and Society: Patients, Professionals and the Dominance of Pharmaceuticals 2008, Palgrave Macmillan, Basingstoke.
34. Dugdale D.C., Epstein R., Pantilat S.Z. Time and the patient-physician relationship. J Gen Intern Med 1999, 14:S34-S40.
35. Barry C.A., Stevenson F.A., Britten N., et al. Giving voice to the life world. More humane, more effective medical care? A qualitative study of doctor-patient communication in general practice. Soc Sci Med 2001, 53:487-505.
36. Fanzing S. Lying, secrecy, and power within the doctor-patient relationship. Anthropol Med 2002, 9:117-133.
37. Bond C., Blenkinsopp A., Raynor D.K. Prescribing and partnership with patients. Br J Clin Pharmacol 2012, 74:581-588.
38. Harrington J., Noble L.M., Newman S.P. Improving patients' communication with doctors: a systematic review of intervention studies. Patient Educ Couns 2004, 52:7-16.
39. Community Pharmacy Use: Market Research Report 2008, Central Office of Information, ContinentalResearch, London, Available at:, Accessed 06.09.12. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_083870.pdf.
40. Eades E.C., Ferguson J.S., O'Carroll R.E. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Publ Health 2011, 11:582.
41. Worley M.M., Schommer J.C., Brown L.M., et al. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?. Res Soc Admin Pharm 2007, 3:47-69.
42. Bissell P., Blenkinsopp A., Short D., et al. Patients' experiences of a community pharmacy-led medicines management service. Health Soc Care Comm 2008, 16:363-369.
43. White L., Klinner C., Carter S. Consumer perspectives of the Australian Home Medicines Review Program: benefits and barriers. Res Social Adm Pharm 2012, 8(1):4-16.
44. Tinelli M., Ryan M., Bond C. Patient preferences for an increased pharmacist role in the management of drug therapy. Int J Pharm Pract 2009, 17:275-282.
45. Geurts M.M., Talsma J., Brouwers J.R., et al. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol 2012, 74:16-33.
46. Chen T.F., De Neto Almeido A. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci 2007, 29:574-576.
47. Hughes C.M., McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 2003, 53:600-606.
48. Chaplin S. The new medicine service to improve adherence to treatment. Prescriber 2011, 22:14-17.
49. Shah B., Chewning B. Conceptualizing and measuring pharmacist-patient communication: a review of published studies. Res Social Adm Pharm 2006, 2:153-185.
50. Medicines Use Review and Prescription Intervention Service 2012, PSNC and NHS Employers, PSNC, London, Available at:, Accessed 06.09.12. http://www.psnc.org.uk/data/files/PharmacyContractandServices/AdvancedServices/MUR_service_spec_-_Sept_2012.pdf.